Why is Vaishali Pharma falling/rising?

As of 04-Jul, Vaishali Pharma Ltd is experiencing a decline in its stock price, currently at 11.43, with a change of -0.02, representing a decrease of 0.17%. The stock has underperformed its sector today by 0.68% and is trading below its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages. Over the past week, the stock has decreased by 0.95%, and it has shown a significant decline of 34.65% year-to-date. The company has been facing operational losses, and its ability to service debt is weak, as indicated by a poor EBIT to Interest ratio of 1.57. Additionally, the stock has generated a return of -32.20% over the past year, which reflects its weak long-term fundamental strength and low profitability per unit of shareholders' funds.
In the broader market context, while the Sensex has increased by 3.42% over the past month, Vaishali Pharma's stock has dropped by 11.53% in the same period, highlighting its underperformance relative to the benchmark. This trend of underperformance is consistent, as the stock has lagged behind the BSE500 over the last three years, one year, and three months. Despite a rise in investor participation, with delivery volume increasing by 130.03% against the 5-day average, the overall sentiment remains negative due to the company's flat results and risky trading conditions compared to its historical valuations.